Outcomes Following Bleeding on Direct Oral Anticoagulants in Patients With Atrial Fibrillation at Liverpool Hospital

Direct oral anticoagulants (DOACs) are vital in atrial fibrillation (AF) stroke prevention. On-treatment bleeding has significant morbidity and mortality. Dabigatran is reversible with an available specific agent; however, the Factor-Xa-Inhibitor (FxaI) reversal-agent has limited availability.

Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: Z. Wang, D. Nguyen, P. Motum, D. Hsu, S. Ng, S. Lo Source Type: research